These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30168974)

  • 1. [Regenerative Therapy of the Cardiovascular Area Using iPS Cells].
    Fukuda K; Tohyama S; Seki T; Yuasa S; Shimoji K; Fujita J
    Nihon Naika Gakkai Zasshi; 2016 Jul; 105(7):1287-95. PubMed ID: 30168974
    [No Abstract]   [Full Text] [Related]  

  • 2. Induced pluripotent stem cells for cardiovascular disease: from product-focused disease modeling to process-focused disease discovery.
    Campbell KA; Terzic A; Nelson TJ
    Regen Med; 2015; 10(6):773-83. PubMed ID: 26439809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects of induced pluripotent stem cell technology in regenerative medicine.
    Zhang F; Citra F; Wang DA
    Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cells in cardiovascular research.
    Sinnecker D; Dirschinger RJ; Goedel A; Moretti A; Lipp P; Laugwitz KL
    Rev Physiol Biochem Pharmacol; 2012; 163():1-26. PubMed ID: 22447279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Making cardiomyocytes: how mechanical stimulation can influence differentiation of pluripotent stem cells.
    Geuss LR; Suggs LJ
    Biotechnol Prog; 2013; 29(5):1089-96. PubMed ID: 23956196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient hepatic differentiation from human iPS cells by gene transfer.
    Kawabata K; Inamura M; Mizuguchi H
    Methods Mol Biol; 2012; 826():115-24. PubMed ID: 22167644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regenerative medicine in cardiovascular diseases - an update.
    Cao Y; Zhang PY
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1335-1340. PubMed ID: 28387893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
    Pan G; Wang T; Yao H; Pei D
    Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future challenges for patient-specific induced pluripotent stem cells in cardiovascular medicine.
    Sun X; Tan G; Liew R
    Expert Rev Cardiovasc Ther; 2012 Aug; 10(8):943-5. PubMed ID: 23030280
    [No Abstract]   [Full Text] [Related]  

  • 10. Induced pluripotent stem cells and their implication for regenerative medicine.
    Csobonyeiova M; Polak S; Koller J; Danisovic L
    Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future perspective of induced pluripotent stem cells for diagnosis, drug screening and treatment of human diseases.
    Lian Q; Chow Y; Esteban MA; Pei D; Tse HF
    Thromb Haemost; 2010 Jul; 104(1):39-44. PubMed ID: 20539907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. iPS cell technology in regenerative medicine.
    Lengner CJ
    Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?
    de Lázaro I; Yilmazer A; Kostarelos K
    J Control Release; 2014 Jul; 185():37-44. PubMed ID: 24746625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Therapeutic Applications of Induced Pluripotent Stem Cells.
    Rami F; Beni SN; Kahnamooi MM; Rahimmanesh I; Salehi AR; Salehi R
    Cell Reprogram; 2017 Apr; 19(2):65-74. PubMed ID: 28266864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic manipulation and studying of differentiation properties of rat induced pluripotent stem cells].
    Liskovykh MA; Chuĭkin IA; Ranjan A; Popova E; Tolkunova EN; Chechik LL; Malinin AIu; Morozova AV; Mosienko V; Bader M; alenina N; Tomilin AN
    Tsitologiia; 2011; 53(12):946-51. PubMed ID: 22359953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem cells: an emerging theranostics platform.
    Nelson TJ; Terzic A
    Clin Pharmacol Ther; 2011 May; 89(5):648-50. PubMed ID: 21512525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New era of regenerative medicine for cardiovascular diseases.
    Tse HF
    Thromb Haemost; 2010 Jul; 104(1):4-5. PubMed ID: 20539908
    [No Abstract]   [Full Text] [Related]  

  • 18. iPS cells--alternative pluripotent cells to embryo stem cells.
    Pei X
    Sci China Life Sci; 2010 Jan; 53(1):154-156. PubMed ID: 20596969
    [No Abstract]   [Full Text] [Related]  

  • 19. Will it be possible to generate kidney tissue from induced pluripotent stem cells for regenerative therapy?
    Osafune K
    Regen Med; 2014 Jan; 9(1):9-12. PubMed ID: 24351001
    [No Abstract]   [Full Text] [Related]  

  • 20. Advances in cell lineage reprogramming.
    Zhou J; Yue W; Pei X
    Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.